Table 1.
Age <45 (n=529)
|
Age ≥45
(n=1,534) |
|||
---|---|---|---|---|
n | % | n | % | |
ER status | ||||
Positive | 219 | 59.2% | 804 | 67.6% |
Negative | 151 | 40.8% | 385 | 32.4% |
SEER stage | ||||
Localized | 225 | 49.7% | 832 | 64.6% |
Regional | 211 | 46.6% | 401 | 31.1% |
Distant | 17 | 3.8% | 55 | 4.3% |
Grade | ||||
Well-differentiated | 36 | 8.5% | 187 | 15.2% |
Moderately differentiated | 146 | 34.4% | 473 | 38.4% |
Poorly or undifferentiated | 243 | 57.2% | 571 | 46.4% |
Tumor size | ||||
≤ 1.0 cm | 81 | 19.8% | 339 | 27.7% |
>1–2.0 cm | 135 | 32.9% | 474 | 38.7% |
>2 cm | 194 | 47.3% | 411 | 33.6% |
ER status was unknown or missing for 159 cases <45 years and 345 cases ≥45 years; SEER stage was unknown or missing for 76 cases <45 years and 246 cases ≥45 years; grade was unknown or missing for 104 cases <45 years and 303 cases ≥45 years; tumor size was missing for 119 cases <45 years and 310 cases ≥45 years.